BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27348064)

  • 1. The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic.
    Barreiro E
    Expert Rev Respir Med; 2016 Sep; 10(9):1011-22. PubMed ID: 27348064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.
    Jaitovich A; Barreiro E
    Am J Respir Crit Care Med; 2018 Jul; 198(2):175-186. PubMed ID: 29554438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory and Limb Muscle Dysfunction in COPD.
    Barreiro E; Gea J
    COPD; 2015 Aug; 12(4):413-26. PubMed ID: 25438125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and muscle dysfunction in chronic obstructive pulmonary disease.
    Barreiro E; Gea J
    Transl Res; 2015 Jan; 165(1):61-73. PubMed ID: 24794953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadriceps muscle weakness and atrophy are associated with a differential epigenetic profile in advanced COPD.
    Puig-Vilanova E; Martínez-Llorens J; Ausin P; Roca J; Gea J; Barreiro E
    Clin Sci (Lond); 2015 Jun; 128(12):905-21. PubMed ID: 25628226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and biological pathways of skeletal muscle dysfunction in chronic obstructive pulmonary disease.
    Barreiro E; Gea J
    Chron Respir Dis; 2016 Aug; 13(3):297-311. PubMed ID: 27056059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diaphragm and skeletal muscle dysfunction in COPD].
    Caron MA; Debigaré R; Dekhuijzen PN; Maltais F
    Rev Mal Respir; 2011 Dec; 28(10):1250-64. PubMed ID: 22152934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of striated muscle dysfunction during acute exacerbations of COPD.
    Gayan-Ramirez G; Decramer M
    J Appl Physiol (1985); 2013 May; 114(9):1291-9. PubMed ID: 23372146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the evaluation and treatment of muscle dysfunction in patients with chronic obstructive pulmonary disease.
    Barreiro E; Bustamante V; Cejudo P; Gáldiz JB; Gea J; de Lucas P; Martínez-Llorens J; Ortega F; Puente-Maestu L; Roca J; Rodríguez-González Moro JM;
    Arch Bronconeumol; 2015 Aug; 51(8):384-95. PubMed ID: 26072153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peripheral muscle dysfunction in chronic obstructive pulmonary disease].
    Maltais F; Leblanc P; Jobin J; Casaburi R
    Rev Mal Respir; 2002 Sep; 19(4):444-53. PubMed ID: 12417861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of cross-sectional area of intercostal muscles in patients with chronic obstructive pulmonary disease.
    Ju S; Lee SJ; Park MJ; Cho YJ; Jeong YY; Jeon KN; Bae K; Lee JD; Kim HC
    Clin Respir J; 2018 Mar; 12(3):939-947. PubMed ID: 28054460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle response to inflammation--lessons for chronic obstructive pulmonary disease.
    Reid WD; Rurak J; Harris RL
    Crit Care Med; 2009 Oct; 37(10 Suppl):S372-83. PubMed ID: 20046123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of muscle dysfunction in COPD.
    Gea J; Agustí A; Roca J
    J Appl Physiol (1985); 2013 May; 114(9):1222-34. PubMed ID: 23519228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory muscles in COPD: regulation of trophical status.
    Decramer M
    Verh K Acad Geneeskd Belg; 2001; 63(6):577-602; discussion 602-4. PubMed ID: 11813511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease.
    Kim HC; Mofarrahi M; Hussain SN
    Int J Chron Obstruct Pulmon Dis; 2008; 3(4):637-58. PubMed ID: 19281080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations.
    Vilaró J; Ramirez-Sarmiento A; Martínez-Llorens JM; Mendoza T; Alvarez M; Sánchez-Cayado N; Vega A; Gimeno E; Coronell C; Gea J; Roca J; Orozco-Levi M
    Respir Med; 2010 Dec; 104(12):1896-902. PubMed ID: 20541383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peripheral muscle dysfunction in chronic obstructive pulmonary disease].
    Roca M; Mihăescu T
    Pneumologia; 2012; 61(3):178-82. PubMed ID: 23173381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do epigenetic events take place in the vastus lateralis of patients with mild chronic obstructive pulmonary disease?
    Puig-Vilanova E; Ausin P; Martinez-Llorens J; Gea J; Barreiro E
    PLoS One; 2014; 9(7):e102296. PubMed ID: 25013984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease. 5: systemic effects of COPD.
    Wouters EF
    Thorax; 2002 Dec; 57(12):1067-70. PubMed ID: 12454303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Global muscle dysfunction and exacerbation of COPD: a cohort study].
    Martínez-Llorens JM; Orozco-Levi M; Masdeu MJ; Coronell C; Ramírez-Sarmiento A; Sanjuas C; Broquetas JM; Gea J
    Med Clin (Barc); 2004 Apr; 122(14):521-7. PubMed ID: 15117643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.